
Trump’s 100% Tariffs on Branded Drugs Put Indian Pharma Stocks Under Pressure
Indian Pharma Faces Heat from US Tariffs The Indian pharmaceutical sector is bracing for fresh turbulence as former US President Donald Trump announced a steep 100% tariff on branded drugs. This move is expected to directly affect leading Indian companies that earn significant revenue from the American market. Background: India’s Strong Pharma Presence in the…